<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37404951</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Systematic Review of the Prevalence of Long COVID.</ArticleTitle><Pagination><StartPage>ofad233</StartPage><MedlinePgn>ofad233</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofad233</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofad233</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Long COVID occurs in those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whose symptoms persist or develop beyond the acute phase. We conducted a systematic review to determine the prevalence of persistent symptoms, functional disability, or pathological changes in adults or children at least 12 weeks postinfection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched key registers and databases from January 1, 2020 to November 2, 2021, limited to publications in English and studies with at least 100 participants. Studies in which all participants were critically ill were excluded. Long COVID was extracted as prevalence of at least 1 symptom or pathology, or prevalence of the most common symptom or pathology, at 12 weeks or later. Heterogeneity was quantified in absolute terms and as a proportion of total variation and explored across predefined subgroups (PROSPERO ID CRD42020218351).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">One hundred twenty studies in 130 publications were included. Length of follow-up varied between 12 weeks and 12 months. Few studies had low risk of bias. All complete and subgroup analyses except 1 had I<sup>2</sup> &#x2265;90%, with prevalence of persistent symptoms range of 0%-93% (pooled estimate [PE], 42.1%; 95% prediction interval [PI], 6.8% to 87.9%). Studies using routine healthcare records tended to report lower prevalence (PE, 13.6%; PI, 1.2% to 68%) of persistent symptoms/pathology than self-report (PE, 43.9%; PI, 8.2% to 87.2%). However, studies systematically investigating pathology in all participants at follow up tended to report the highest estimates of all 3 (PE, 51.7%; PI, 12.3% to 89.1%). Studies of hospitalized cases had generally higher estimates than community-based studies.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The way in which Long COVID is defined and measured affects prevalence estimation. Given the widespread nature of SARS-CoV-2 infection globally, the burden of chronic illness is likely to be substantial even using the most conservative estimates.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Woodrow</LastName><ForeName>Mirembe</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6113-0050</Identifier><AffiliationInfo><Affiliation>School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carey</LastName><ForeName>Charles</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6121-7399</Identifier><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziauddeen</LastName><ForeName>Nida</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration Wessex, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akrami</LastName><ForeName>Athena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sainsbury Wellcome Centre, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Patient-led Research Collaborative, Washington, District of Columbia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lutje</LastName><ForeName>Vittoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cochrane Infectious Diseases Group, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenwood</LastName><ForeName>Darren C</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0001-7035-3096</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alwan</LastName><ForeName>Nisreen A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration Wessex, Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Southampton Biomedical Research Centre, University of Southampton, and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>Potential conflicts of interest. DCG is a coinvestigator on the NIHR-funded LOCOMOTION study. NAA has lived experience of Long COVID, is a coinvestigator on the NIHR-funded STIMULATE-ICP and HI-COVE studies, has contributed in an advisory capacity to World Health Organization (WHO) and the European Union Commission's Expert Panel on effective ways of investing in health meetings in relation to post-COVID-19 condition, and has acted as a collaborator on some of the UK's Office for National Statistics outputs on the prevalence of Long COVID. AA has lived experience of Long COVID, is a co-founder of the Patient-Led Research Collaborative, and has contributed in an advisory capacity to National Institutes of Health, Centers for Disease Control and Prevention, and WHO. All authors: No reported conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37404951</ArticleId><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofad233</ArticleId><ArticleId IdType="pii">ofad233</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization . A clinical case definition of post COVID-19 condition by a Delphi consensus. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed 5 November 2022.</Citation></Reference><Reference><Citation>
National Institute for Health and Care Excellence (NICE) . COVID-19 rapid guideline: managing the long-term effects of COVID-19. Available at: https://www.nice.org.uk/guidance/NG188. Accessed 5 November 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention (CDC) . Post-COVID Conditions: Overview for Healthcare Providers. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html#. Accessed 5 November 2022.</Citation></Reference><Reference><Citation>Nehme M, Braillard O, Alcoba G, et al. . COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med 2021; 174:723&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME, et al. . Characteristics and impact of long Covid: findings from an online survey. PLoS One 2022; 17:e0264331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine 2021; 38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. . Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res 2020; 20:1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T, Taylor AK, Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the &#x2018;right&#x2019; GP: a qualitative study of the experiences of people with long-COVID. BJGP Open 2020; 4:bjgpopen20X101143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics . Technical article: updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021. Office for National Statistics, 2021. Available at https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021. Accessed 23 March 2023.</Citation></Reference><Reference><Citation>
World Health Organization . WHO COVID-19 research database. Available at: https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/. Accessed 2 November 2021 .</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>StataCorp . Stata statistical software: release 17. College Station: StataCorp LLC, 2021.</Citation></Reference><Reference><Citation>Migliavaca CB, Stein C, Colpani V, et al. . Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity. Res Synth Methods 2022; 13:363&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35088937</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 2009; 172:137&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2667312</ArticleId><ArticleId IdType="pubmed">19381330</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman MM, Abd-Elrahman NM, Bakheet TM. Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study. J Med Virol 2021; 93:5942&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426945</ArticleId><ArticleId IdType="pubmed">34171139</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021; 594:259&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021; 27:1607&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminian A, Bena J, Pantalone KM, Burguera B. Association of obesity with postacute sequelae of COVID-19. Diabetes Obes Metab 2021; 23:2183&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239834</ArticleId><ArticleId IdType="pubmed">34060194</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Fergus WH, Alice M, et al. . Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. Thorax 2021; 76:399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. . Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021; 6:100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, et al. . Post-syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021; 372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Baricich A, Borg MB, Cuneo D, et al. . Midterm functional sequelae and implications in rehabilitation after COVID-19: a cross-sectional study. Eur J Phys Rehabil Med 2021; 57:199&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">33565741</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JH, Lin JJ, Doernberg M, et al. . Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open 2021; 4:e2130645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, et al. . Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open 2021; 4:e2036142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco JR, Cobos-Ceballos MJ, Navarro F, et al. . Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect 2021; 27:892&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7920814</ArticleId><ArticleId IdType="pubmed">33662544</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S, Banasik K, Pedersen OB, et al. . Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep 2021; 11:13153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Guida F, Polesel J, et al. . Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol 2021; 11:1685&#x2013;1688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Garcia P, Garmendia-Prieto B, Cristofori G, et al. . Health status in survivors older than 70 years after hospitalization with COVID-19: observational follow-up study at 3 months. Eur Geriatr Med 2021; 12:1091&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8165338</ArticleId><ArticleId IdType="pubmed">34057701</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso D, Guido G, Zerunian M, et al. . Post-acute sequelae of COVID-19 pneumonia: six-month chest CT follow-up. Radiology 2021; 301:E396&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8335814</ArticleId><ArticleId IdType="pubmed">34313468</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol 2022; 37:539&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro VM, Rosand J, Giacino JT, McCoy TH, Perlis RH. Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems. Mol Psychiatry 2022; 27:3898&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9199464</ArticleId><ArticleId IdType="pubmed">35705635</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai C, Feng X, Lu M, et al. . One-year mortality and consequences of COVID-19 in cancer patients: a cohort study. IUBMB Life 2021; 73:1244&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426703</ArticleId><ArticleId IdType="pubmed">34318585</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Schiabor Barrett KM, Riffle S, et al. . Long-term COVID-19 symptoms in a large unselected population [preprint]. medRxiv 2020. 10.1101/2020.10.07.20208702</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavario P, De Marzo V, Lotti R, et al. . Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up. Int J Cardiol 2021; 340:113&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8302817</ArticleId><ArticleId IdType="pubmed">34311011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristillo V, Pilotto A, Cotti Piccinelli S, et al. . Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection. J Am Geriatr Soc 2021; 69:2778&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242714</ArticleId><ArticleId IdType="pubmed">34019707</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Fuentes G, Roa-Gomez G, Reyes O, Singhal R, Venkatram S. Coronavirus pneumonia: outcomes and characteristics of patients in an inner-city area after 3 months of infection. J Clin Med 2021; 10:3368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8347142</ArticleId><ArticleId IdType="pubmed">34362155</ArticleId></ArticleIdList></Reference><Reference><Citation>Domenech-Montoliu S, Puig-Barbera J, Pac-Sa MR, et al. . ABO blood groups and the incidence of complications in COVID-19 patients: a population-based prospective cohort study. Int J Environ Res Public Health 2021; 18:10039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8507737</ArticleId><ArticleId IdType="pubmed">34639344</ArticleId></ArticleIdList></Reference><Reference><Citation>Erol N, Alpinar A, Erol C, Sari E, Alkan K. Intriguing new faces of Covid-19: persisting clinical symptoms and cardiac effects in children. Cardiol Young 2022; 32:1085&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438511</ArticleId><ArticleId IdType="pubmed">34407902</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, Leavy OC, Richardson M, et al. . Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med 2022; 10:761&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021; 9:1275&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Gomez-Mayordomo V, de-la-Llave-Rincon AI, et al. . Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: a multicenter study. J Infect 2021; 83:496&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236125</ArticleId><ArticleId IdType="pubmed">34192525</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Guijarro C, Plaza-Canteli S, Hernandez-Barrera V, Torres-Macho J. Prevalence of post-COVID-19 cough one year after SARS-CoV-2 infection: a multicenter study. Lung 2021; 199:249&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8124095</ArticleId><ArticleId IdType="pubmed">33993321</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, et al. . Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: a multicenter study. J Infect 2021; 83:237&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110627</ArticleId><ArticleId IdType="pubmed">33984399</ArticleId></ArticleIdList></Reference><Reference><Citation>Frija-Masson J, Debray MP, Boussouar S, et al. . Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: the post Covid M3 study. Respir Med 2021; 184:106435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8123365</ArticleId><ArticleId IdType="pubmed">34020126</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A, Mahsouli A, Liistro G, et al. . Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir Med 2021; 181:106383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="pubmed">33839588</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L, Fang Y, Luo D, et al. . Pre-hospital, in-hospital and post-hospital factors associated with sleep quality among COVID-19 survivors 6 months after hospital discharge: cross-sectional survey in five cities in China. BJPsych Open 2021; 7:e191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505817</ArticleId><ArticleId IdType="pubmed">34659795</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber TAK, Ashish A, Unsworth A. Persistent post-covid symptoms in healthcare workers. Occup Med (Oxford) 2021; 71:144&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083525</ArticleId><ArticleId IdType="pubmed">33830208</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Abellan J, Padilla S, Fernandez-Gonzalez M, et al. . Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study. J Clin Immunol 2021; 41:1490&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Garratt AM, Ghanima W, Einvik G, Stavem K. Quality of life after COVID-19 without hospitalisation: good overall, but reduced in some dimensions. J Infect 2021; 82:186&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834148</ArticleId><ArticleId IdType="pubmed">33434590</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Hermosillo JA, Martinez-Lopez JP, Carrillo-Lampon SA, et al. . Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican cohort. Brain Sci 2021; 11:760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Fan Y, Alwalid O, et al. . Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology 2021; 299:E177&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, et al. . Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA 2021; 325:2015&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England) 2021; 397:220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. . 1-year Outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet (London, England) 2021; 398:747&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, Rao M, Bonilla H, et al. . Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis 2021; 73:e826&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashif A, Chaudhry M, Fayyaz T, et al. . Follow-up of COVID-19 recovered patients with mild disease. Sci Rep 2021; 11:13414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239036</ArticleId><ArticleId IdType="pubmed">34183705</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Kim S-W, Chang H-H, Kwon KT, Bae S, Hwang S. Significance and associated factors of long-term sequelae in patients after acute COVID-19 infection in Korea. Infect Chemother 2021; 53:463&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511373</ArticleId><ArticleId IdType="pubmed">34405592</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemhofer C, Sturm C, Loudovici-Krug D, Best N, Gutenbrunner C. The impact of post-COVID-syndrome on functioning&#x2014;results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. J Occup Med Toxicol 2021; 16:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8495185</ArticleId><ArticleId IdType="pubmed">34620202</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Shen C, Wang L, et al. . Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study. Respir Res 2021; 22:203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8267229</ArticleId><ArticleId IdType="pubmed">34243776</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao T, Meng D, Xiong L, et al. . Long-term effects of COVID-19 on health care workers 1-year post-discharge in Wuhan. Infect Dis Ther 2022; 11:145&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536919</ArticleId><ArticleId IdType="pubmed">34687442</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X, Wang Y, He Z, et al. . Three-month pulmonary function and radiological outcomes in COVID-19 survivors: a longitudinal patient cohort study. Open Forum Infect Dis 2021; 8:ofaa540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717449</ArticleId><ArticleId IdType="pubmed">34667824</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y-H, Wang Y-R, Wang Q-H, et al. . Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener 2021; 16:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287105</ArticleId><ArticleId IdType="pubmed">34281568</ArticleId></ArticleIdList></Reference><Reference><Citation>Liyanage-Don NA, Cornelius T, Sanchez JE, et al. . Psychological distress, persistent physical symptoms, and perceived recovery after COVID-19 illness. J Gen Intern Med 2021; 36:2525&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118366</ArticleId><ArticleId IdType="pubmed">33987793</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. . Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 2021; 4:e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucidi D, Molinari G, Silvestri M, et al. . Patient-reported olfactory recovery after SARS-CoV-2 infection: a 6-month follow-up study. Int Forum Allergy Rhinol 2021; 11:1249&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">33539667</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS, et al. . Long COVID in patients with mild to moderate disease: do thyroid function and autoimmunity play a role? Endocr Pract 2021; 27:894&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257401</ArticleId><ArticleId IdType="pubmed">34237471</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Muniz MM, Arias A, Mata-Vazquez E, et al. . Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med 2021; 10:2945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez AE, Banderet F, Labhardt ND, Battegay M. Long-term outcome after SARS-CoV-2 infection in healthcare workers: a single centre cohort study. Swiss Med Wkly 2021; 151:w30094.</Citation><ArticleIdList><ArticleId IdType="pubmed">34694107</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteudi T, Luciani L, Fabre A, et al. . Clinical characteristics of paediatric COVID-19 patients followed for up to 13 months. Acta Paediatr 2021; 110:3331&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444774</ArticleId><ArticleId IdType="pubmed">34403523</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, et al. . Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun 2021; 94:138&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mechi A, Al-Khalidi A RALD, Al-Dujaili MN, et al. . Long-term persistent symptoms of COVID-19 infection in patients with diabetes mellitus. Int J Diabetes Dev Ctries 2022; 42:49&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8382933</ArticleId><ArticleId IdType="pubmed">34456528</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Q, Wang F, Bryant A, Wei L, Yuan X, Li J. Mental health problems among COVID-19 survivors in Wuhan, China. World Psychiatry 2021; 20:139&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801855</ArticleId><ArticleId IdType="pubmed">33432745</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Q, Wang F, Yang Y, et al. . Health issues and immunological assessment related to Wuhan&#x2019;s COVID-19 survivors: a multicenter follow-up study. Front Med (Lausanne) 2021; 8:617689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8138053</ArticleId><ArticleId IdType="pubmed">34026775</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, Ballouz T, Anagnostopoulos A, et al. . Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS One 2021; 16:e0254523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M, Anselmo M, Buscaglia S, et al. . COVID-19 6 months after hospital discharge: pulmonary function impairment and its heterogeneity. ERJ Open Res 2021; 7:00196-2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8215495</ArticleId><ArticleId IdType="pubmed">34285908</ArticleId></ArticleIdList></Reference><Reference><Citation>Millet C, Narvaneni S, Chaudhry S, et al. . The long haul: a follow up study of patients diagnosed with COVID-19 one year ago at an urban medical center in New Jersey. Chest 2021; 160:A566&#x2013;A7.</Citation></Reference><Reference><Citation>Mohiuddin Chowdhury ATM, Karim MR, Ali MA, Islam J, Li Y, He S. Clinical characteristics and the long-term post-recovery manifestations of the COVID-19 patients&#x2014;a prospective multicenter cross-sectional study. Front Med (Lausanne) 2021; 8:663670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416537</ArticleId><ArticleId IdType="pubmed">34490284</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, et al. . Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy 2021; 51:1107&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabahati M, Ebrahimpour S, Khaleghnejad Tabari R, Mehraeen R. Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study. Egypt J Radiol Nucl Med 2021; 52:248.</Citation></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I, CoviCare Study T. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med 2021; 174:1252&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N, Hoang VT, Lagier JC, Raoult D, Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect 2021; 27:931&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7784539</ArticleId><ArticleId IdType="pubmed">33418020</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunez-Fernandez M, Ramos-Hernandez C, Garcia-Rio F, et al. . Alterations in respiratory function test three months after hospitalisation for COVID-19 pneumonia: value of determining nitric oxide diffusion. J Clin Med 2021; 10:2119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8153552</ArticleId><ArticleId IdType="pubmed">34068867</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Keefe JB, Minton HC, Morrow M, et al. . Postacute sequelae of SARS-CoV-2 infection and impact on quality of life 1&#x2013;6 months after illness and association with initial symptom severity. Open Forum Infect Dis 2021; 8:ofab352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360237</ArticleId><ArticleId IdType="pubmed">34395709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong SWX, Fong S-W, Young BE, et al. . Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open Forum Infect Dis 2021; 8:ofab156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083585</ArticleId><ArticleId IdType="pubmed">34095336</ArticleId></ArticleIdList></Reference><Reference><Citation>Orru G, Bertelloni D, Diolaiuti F, et al. . Long-COVID syndrome? A study on the persistence of neurological, psychological and physiological symptoms. Healthcare (Basel, Switzerland) 2021; 9:575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I, Spiridonova E, Bobkova P, et al. . Risk factors for long covid in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study. Eur Respir J 2021; 59:2101341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. . Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 2021; 27:1507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Kelly JD, Lu S, et al. . Persistence, Magnitude, and Patterns of Postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect Dis 2021; 9:ofab640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M, Kristiansen MF, Hanusson KD, et al. . Long COVID in the Faroe Islands&#x2014;a longitudinal study among non-hospitalized patients. Clin Infect Dis 2021; 73:e4058&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W, Chen S, Zhang Y, et al. . Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J 2021; 58:2003677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877322</ArticleId><ArticleId IdType="pubmed">33574077</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu G, Zhen Q, Wang W, et al. . Health-related quality of life of COVID-19 patients after discharge: a multicenter follow-up study. J Clin Nurs 2021; 30(11-12):1742&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013595</ArticleId><ArticleId IdType="pubmed">33656210</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA 2021; 326:869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, et al. . Neurological outcome and quality of life 3 months after COVID-19: a prospective observational cohort study. Eur J Neurol 2021; 28:3348&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Riestra-Ayora J, Yanes-Diaz J, Esteban-Sanchez J, et al. . Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers. Eur Arch Otorhinolaryngol 2021; 278:4831&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8004560</ArticleId><ArticleId IdType="pubmed">33774737</ArticleId></ArticleIdList></Reference><Reference><Citation>Righi E, Mirandola M, Mazzaferri F, et al. . Long-term patient-centred follow-up in a prospective cohort of patients with COVID-19. Infect Dis Ther 2021; 10:1579&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8215633</ArticleId><ArticleId IdType="pubmed">34152573</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M, Tesch F, Batram M, et al. . Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19 [preprint]. medRxiv 2021. 10.1101/2021.10.21.21265133</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.21.21265133</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Duarte A, Rivera-Izquierdo M, de Alba IG-F, et al. . Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med 2021; 19:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathyamurthy P, Madhavan S, Pandurangan V. Prevalence, pattern and functional outcome of post COVID-19 syndrome in older adults. Cureus 2021; 13:e17189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8369971</ArticleId><ArticleId IdType="pubmed">34422503</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al. . Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis 2022; 74:1191&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang YF, Liu T, Yu JN, et al. . Half-year follow-up of patients recovering from severe COVID-19: analysis of symptoms and their risk factors. J Intern Med 2021; 290:444&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242565</ArticleId><ArticleId IdType="pubmed">33904618</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibila O, Albacar N, Perea L, et al. . Lung function sequelae in COVID-19 patients 3 months after hospital discharge. Arch Bronconeumol 2021; 57:59&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903150</ArticleId><ArticleId IdType="pubmed">34629656</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al. . Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur 2021; 8:100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L, Ramezani M, Darazam IA, et al. . Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol 2021; 27: 154&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Skala M, Svoboda M, Kopecky M, et al. . Heterogeneity of post-COVID impairment: interim analysis of a prospective study from Czechia. Virol J 2021; 18:73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8040356</ArticleId><ArticleId IdType="pubmed">33845839</ArticleId></ArticleIdList></Reference><Reference><Citation>Skjorten I, Ankerstjerne OAW, Trebinjac D, et al. . Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J 2021; 58:2100996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247555</ArticleId><ArticleId IdType="pubmed">34210791</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et al. . Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J 2021; 57:2003481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraas A, Bo R, Kalleberg KT, Stoer NC, Ellingjord-Dale M, Landro NI. Self-reported memory problems 8 months after COVID-19 infection. JAMA Netw Open 2021; 4:e2118717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8322992</ArticleId><ArticleId IdType="pubmed">34323987</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraas A, Kalleberg KT, Dahl JA, et al. . Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PLoS One 2021; 16:e0256142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389372</ArticleId><ArticleId IdType="pubmed">34437579</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax 2021; 76:405&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health 2021; 18:2030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7921928</ArticleId><ArticleId IdType="pubmed">33669714</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Shafran R, De Stavola B, et al. . Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study). BMJ Open 2021; 11:e052838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021; 27:626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung 2021; 199:113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Carinena A, Moreno E, et al. . Post-COVID-19 functional status six-months after hospitalization. J Infect 2021; 82:e31&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021; 18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month Neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. e Lancet Psychiatry 2021; 8:416&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarsitani L, Vassalini P, Koukopoulos A, et al. . Post-traumatic stress disorder among COVID-19 survivors at 3-month follow-up after hospital discharge. J Gen Intern Med 2021; 36:1702&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007055</ArticleId><ArticleId IdType="pubmed">33782888</ArticleId></ArticleIdList></Reference><Reference><Citation>Tawfik HM, Shaaban HM, Tawfik AM. Post-COVID-19 syndrome in Egyptian healthcare staff: highlighting the carers sufferings. Electron J Gen Med 2021; 18:em291.</Citation></Reference><Reference><Citation>Taylor R, Trivedi B, Patel N, et al. . Post-COVID symptoms reported at asynchronous virtual review and stratified follow-up after COVID-19 pneumonia. Clin Med (Lond) 2021; 21:e384&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8313189</ArticleId><ArticleId IdType="pubmed">34103378</ArticleId></ArticleIdList></Reference><Reference><Citation>Tempany M, Leonard A, Prior AR, et al. . The potential impact of post-COVID symptoms in the healthcare sector. Occup Med (Oxford, England) 2021; 71:284&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34415352</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the CSG; Morin L, Savale L, Pham T, et al. . Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA 2021; 325:1525&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Tholin B, Ghanima W, Einvik G, et al. . Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis. Br J Haematol 2021; 194:542&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239792</ArticleId><ArticleId IdType="pubmed">34028814</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Saddik B, AlSwaidan N, et al. . Prevalence and predictors of post-acute COVID-19 syndrome (PACS) after hospital discharge: a cohort study with 4 months median follow-up. PLoS One 2021; 16:e0260568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8651136</ArticleId><ArticleId IdType="pubmed">34874962</ArticleId></ArticleIdList></Reference><Reference><Citation>Todt BC, Szlejf C, Duim E, et al. . Clinical outcomes and quality of life of COVID-19 survivors: a follow-up of 3 months post hospital discharge. Respir Med 2021; 184:106453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116128</ArticleId><ArticleId IdType="pubmed">34010740</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohamy D, Sharaf M, Abdelazeem K, et al. . Ocular manifestations of post-acute COVID-19 syndrome, upper Egypt early report. J Multidiscip Healthc 2021; 14:1935&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315779</ArticleId><ArticleId IdType="pubmed">34326644</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, et al. . Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One 2020; 15:e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Trunfio M, Venuti F, Alladio F, et al. . Diagnostic SARS-CoV-2 cycle threshold value predicts disease severity, survival, and six-month sequelae in COVID-19 symptomatic patients. Viruses 2021; 13:281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917896</ArticleId><ArticleId IdType="pubmed">33670360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F, Ciaffi J, Mancarella L, et al. . Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open 2021; 7:e001735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Benatti SV, Casati M, et al. . Surviving COVID-19 in Bergamo Province: a post-acute outpatient re-evaluation. Epidemiol Infect 2021; 149:e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Walle-Hansen MM, Ranhoff AH, Mellingsaeter M, Wang-Hansen MS, Myrstad M. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr 2021; 21:199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7983098</ArticleId><ArticleId IdType="pubmed">33752614</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J, Li Y, Li J, et al. . Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol Hepatol 2021; 6:344&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. . Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 2022; 13:1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong L, Li Q, Cao X, et al. . Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study. BMC Med 2021; 19:163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8277525</ArticleId><ArticleId IdType="pubmed">34256745</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. . Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021; 27:89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B, Song L, Guo J, Wang Y, Peng L, Li D. Association between clinical characteristics and short-term outcomes in adult male COVID-19 patients with mild clinical symptoms: a single-center observational study. Front Med (Lausanne) 2021; 7:571396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7813813</ArticleId><ArticleId IdType="pubmed">33469542</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X, Huang H, Wang C, et al. . Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery. J Infect 2021; 83:381&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164517</ArticleId><ArticleId IdType="pubmed">34062186</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Xi X, Min X, et al. . Long-term chest CT follow-up in COVID-19 survivors: 102&#x2013;361 days after onset. Ann Transl Med 2021; 9:1231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8421980</ArticleId><ArticleId IdType="pubmed">34532368</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S, Zahra H, Royer P-Y, et al. . Post-COVID-19 syndrome: nine months after SARS-CoV-2 infection in a cohort of 354 patients: data from the first wave of COVID-19 in Nord Franche-Comte Hospital, France. Microorganisms 2021; 9:1719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401026</ArticleId><ArticleId IdType="pubmed">34442798</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, Zhu Y, Wang S, et al. . SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection. Signal Transduct Target Ther 2021; 6:368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8512652</ArticleId><ArticleId IdType="pubmed">34645784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Zhang C, Li X, et al. . Thin-section computed tomography findings and longitudinal variations of the residual pulmonary sequelae after discharge in patients with COVID-19: a short-term follow-up study. Eur Radiol 2021; 31:7172&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7950423</ArticleId><ArticleId IdType="pubmed">33704519</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Xu J, Zhou S, et al. . The characteristics of 527 discharged COVID-19 patients undergoing long-term follow-up in China. Int J Infect Dis 2021; 104:685&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848496</ArticleId><ArticleId IdType="pubmed">33540129</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y, et al. . Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Network Open 2021; 4:e2127403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Xu J, Liao T, et al. . Comparison of residual pulmonary abnormalities 3 months after discharge in patients who recovered from COVID-19 of different severity. Front Med (Lausanne) 2021; 8:682087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8270002</ArticleId><ArticleId IdType="pubmed">34249973</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, et al. . Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2021; 76:399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully EP, Schumock G, Fu M, et al. . Sex and gender differences in testing, hospital admission, clinical presentation, and drivers of severe outcomes from COVID-19. Open Forum Infect Dis 2021; 8:ofab448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8465334</ArticleId><ArticleId IdType="pubmed">34584899</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21:133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 3 November 2022. Office for National Statistics. 2022. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/3november2022. Accessed 5 November 2022.</Citation></Reference><Reference><Citation>Griffith GJ, Morris TT, Tudball MJ, et al. . Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun 2020; 11:5749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference><Reference><Citation>Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol 2013; 177:292&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3626058</ArticleId><ArticleId IdType="pubmed">23371353</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics . Self-reported long COVID after infection with the Omicron variant in the UK: 18 July 2022. Office for National Statistics. 2022. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/18july2022. Accessed 5 November 2022.</Citation></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, et al. . Risk of long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study. Open Forum Infect Dis 2022; 9:ofac464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>